Related Experiment Video
Updated: Apr 1, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
Published on: July 17, 2013
Atypical giant chondroblastoma mimicking a chondrosarcoma
Sunita Dhanda1, Santosh Menon, Ashish Gulia
1Department of Radiology, Tata Memorial Centre, Dr. Ernest Borges Marg, Parel, Mumbai, Maharashtra, India.
Chondroblastoma, a rare benign bone tumor, can present atypically, even in flat bones. This case highlights unusual radiological features and age non-concordance in chondroblastoma.
Area of Science:
- Orthopedic Oncology
- Skeletal Radiology
- Tumor Biology
Background:
- Chondroblastoma is a rare, benign tumor originating from chondroblasts.
- Typically affects the epiphysis of long bones in adolescents and young adults.
- Rarely, chondroblastomas can occur in flat bones, such as the scapula.
Observation:
- This case report details a chondroblastoma with atypical radiological findings.
- The tumor presented with features not typically associated with its usual presentation.
- Age non-concordance was noted, deviating from the common second-decade presentation.
Findings:
- Histologically typical chondroblastoma can exhibit aggressive behaviors.
- These aggressive behaviors include large size, pulmonary metastases, and local recurrence.
- Atypical presentations challenge standard diagnostic criteria for chondroblastoma.
Implications:
- Highlights the importance of considering chondroblastoma in differential diagnoses for bone lesions with unusual imaging characteristics.
- Emphasizes the need for thorough evaluation, even in cases with seemingly benign histology.
- Underscores the potential for aggressive behavior in chondroblastomas, regardless of typical presentation patterns.
More Related Videos
07:18Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024